Methods : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [1]
Blood samples were collected from four non-smoking, healthy, male volunteers with ages ranging from 27 to 56 years. Although having lifestyle-related diseases and receiving medication, these donors had no hindrance in daily life. The study design and consent forms for all procedures performed with the study subjects were approved by the ethical committee for human subjects at Niigata University School of Medicine in accordance with the Helsinki Declaration of 1975 as revised in 2008.
As described previously [6, 15, 16], blood samples (~9.0 mL) collected without anticoagulants using vacuum plain glass tubes (A-PRF+; Jiangxi Fenglin Medical Technology Co. Ltd., Fengcheng, China) or conventional vacuum plain glass tube (Plain BD Vacutainer Tube; Becton, Dickinson and Company, Franklin Lakes, NJ, USA) from the same donors were immediately centrifuged by an A-PRF centrifugation system (A-PRF12; DRAGON LABORATORY Instruments Ltd., Beijing, China) or a Medifuge centrifugation system (Silfradent S. r. l., Santa Sofia, Italy). After eliminating the red blood cell (RBC) fractions, the resulting A-PRF and CGF clots were compressed using a stainless-steel compression device and preserved between wet gauze until mechanical testing (usually for a maximum of 3 h).
To prepare platelet-poor plasma (PPP), peripheral blood (~9.0 mL) was collected using syringes containing A-formulation of acid-citrate-dextrose (ACD-A) (1.0 mL; Terumo, Tokyo, Japan) and immediately fractionated by the conventional double-spin method [17, 18]. The supernatant was collected as the PPP fraction. To prepare fibrin clots, bovine thrombin (Liquid Thrombin MOCHIDA Softbottle, Mochida Pharmaceutical Co. Ltd., Tokyo, Japan) was added to the PPP at a final volume percentage of 2.5% (v/v) at ambient temperature in glass chambers. The resulting PPP clots, which is designated as platelet-poor, thrombin-activated fibrin (PPTF), were compressed and preserved between wet gauze until mechanical testing (usually for a maximum of 3 h).
After excess amounts of exudate were quickly absorbed by the dry gauze, wet weights of freshly prepared A-PRF, CGF, and PPTF clots were measured using an electric balance. After compression with the stainless compressor, their weights were measured again. The compressed clots were then dried by heating at 140 °C for 30 min and were weighed in a pre-heated moisture analyzer (MA35; Sartorius Corporate Administration GmbH, Goettingen, Germany).
Serial posts:
- Abstract : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Background : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [1]
- Background : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [2]
- Methods : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [1]
- Methods : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [2]
- Methods : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [3]
- Results : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Discussion : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [1]
- Discussion : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [2]
- Conclusions : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Abbreviations : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- References : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [1]
- References : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [2]
- Author information : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [1]
- Author information : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF) [2]
- Rights and permissions : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- About this article : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Table 1 Similarity in size and stretching property of A-PRF and CGF membranes : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Table 2 Comparison of water content of A-PRF, CGF, and PPTF clots : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Table 3 Summaries of preparation procedures, relative mechanical, degradation, and related properties of A-PRF, CGF and PPTF : Mechanical and degradation properties of advanced platelet-rich fibrin (A-PRF), concentrated growth factors (CGF), and platelet-poor plasma-derived fibrin (PPTF)
- Fig. 1. Surface microstructures of A-PRF, CGF, and fibrin clots prepared by PPP + CaCl2 and PPTF (fibrin clots prepared by PPP and thrombin). Similar observations were obtained from other three independent blood samples. Scale bar = 10 μm. Note: the same magnification (×9000) was used in all the SEM images shown here : Mechanical and degradation properties of advanced
- Fig. 2. Representative stress-strain curves for A-PRF and CGF membranes and mechanical properties (Young’s modulus, strain at break, and maximum stress) of A-PRF, CGF, and PPTF membranes. N = 3–9 : Mechanical and degradation properties of advanced
- Fig. 3. Enzymatic degradability of A-PRF, CGF, and PPTF membranes. Each membrane disk (φ8 mm, 1 mm thick) was immersed in PBS containing trypsin and incubated in a CO2 incubator. N = 4. The asterisks represent significant differences (P < 0.05) compared with A-PRF at the same time points : Mechanical and degradation properties of advanced